New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc.
Industry: Life Sciences ・ $DAWN on Nasdaq ・ Market Cap: Small
CEO Recent Sales
Top Executive Recent Sales
Regular Sale Insiders
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
TRADES PURCHASE/SALE Sector Average | 0 / 32 2.19 / 7.65 |
INSIDER BUYERS/SELLERS Sector Average | 0 / 5 1.2 / 2.5 |
SHARES PURCHASED/SOLD Transaction Average | 0 / 428,615 0 / 13,394 |
VALUE PURCHASED/SOLD Transaction Average | $0 / $6,683,146 $0 / $208,848 |
PURCHASE RANGE | N/A |
SALE RANGE | $8,010 - $1,417,084.79 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
0 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
2 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
No Insider Trades made
0%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | N/A 0.2 |
VALUE GINI INDEX Sector Average | N/A 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
31.58%
DIRECTORS
68.42%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.445 0.295 |
VALUE GINI INDEX Sector Average | 0.453 0.288 |
Day One Biopharmaceuticals, Inc. 1Y Trade Transactions
Submission Date Period of Report | Insider | Position | Total Value | Shares | Share Price | Ownership % Change | Shares Owned | Post Day Stock Change | Post Week Stock Change | |
---|---|---|---|---|---|---|---|---|---|---|
2025-02-21 2025-02-15 | York Charles N II | Officer | -$52,265 | 4,370 | $11.96 | -1.7% | 252,638 | N/A | N/A | |
2025-02-21 2025-02-15 | Dubow Adam | Officer | -$55,566 | 4,646 | $11.96 | -10.5% | 39,602 | N/A | N/A | |
2025-02-21 2025-02-15 | Bender Jeremy | Director | -$144,094 | 12,048 | $11.96 | -0.69% | 1,736,853 | N/A | N/A | |
2024-12-12 2024-12-10 | Blackman Samuel C. | Officer | -$399,300 | 30,000 | $13.31 | -1.45% | 2,034,015 | -1.48% | -4.76% | |
2024-11-19 2024-11-15 | Bender Jeremy | Director | -$139,418 | 10,554 | $13.21 | -0.61% | 1,717,215 | N/A | N/A | |
2024-11-19 2024-11-15 | Blackman Samuel C. | Officer | -$29,141 | 2,206 | $13.21 | -0.11% | 2,064,015 | N/A | N/A | |
2024-11-19 2024-11-15 | Dubow Adam | Officer | -$41,810 | 3,165 | $13.21 | -8.96% | 32,162 | N/A | N/A | |
2024-11-19 2024-11-15 | York Charles N II | Officer | -$34,372 | 2,602 | $13.21 | -1.07% | 240,133 | N/A | N/A | |
2024-11-12 2024-11-08 | Blackman Samuel C. | Officer | -$456,036 | 28,255 | $16.14 | -1.35% | 2,057,535 | -8.44% | -12.92% | |
2024-11-04 2024-10-31 | Blackman Samuel C. | Officer | -$8,010 | 500 | $16.02 | -0.02% | 2,097,035 | +6.41% | +5.60% |